{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T13:52:56Z","timestamp":1781185976448,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA015815"],"award-info":[{"award-number":["UG1DA015815"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA037441"],"award-info":[{"award-number":["R01DA037441"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002369"],"award-info":[{"award-number":["UL1TR002369"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Little is known about patient characteristics that contribute to initiating antiretroviral therapy (ART) and achieving viral suppression among HIV people with opioid use disorder in Vietnam. The primary objective of this analysis was to evaluate associations between participant characteristics and the critical steps in the HIV care continuum of ART initiation and HIV viral suppression among people with opioid use disorder and HIV in Vietnam.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We assessed baseline participant characteristics, ART status, and HIV viral suppression (HIV RNA PCR\u2009&lt;\u2009200 copies\/mL) enrolled in a clinical trial of HIV clinic-based buprenorphine versus referral for methadone among people with opioid use disorder in Vietnam. We developed logistic regression models to identify characteristics associated with ART status and HIV viral suppression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 283 study participants, 191 (67.5%) were prescribed ART at baseline, and 168 of those on ART (90%) were virally suppressed. Years since HIV diagnosis (aOR\u2009=\u20091.12, 95% CI 1.06, 1.19) and being married (aOR\u2009=\u20092.83, 95% CI 1.51, 5.34) were associated with an increased likelihood of current prescription for ART at baseline. Greater depression symptoms were negatively associated with receipt of ART (aOR\u2009=\u20090.97, 95% CI\u2009=\u2009(0.94, 0.9963)). In the HIV suppression model, once adjusting for all included covariates, only receipt of ART was associated with viral suppression (aOR\u2009=\u200925.9, 95% CI\u2009=\u2009(12.5, 53.8). In bivariate analyses, methamphetamine was negatively correlated with ART prescription (<jats:italic>p<\/jats:italic>\u2009=\u20090.07) and viral suppression (<jats:italic>p<\/jats:italic>\u2009=\u20090.08).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>While fewer than 90% of participants had received ART, 90% of those on ART had achieved HIV viral suppression at baseline, suggesting that interventions to improve uptake of ART in Vietnam are essential for achieving UNAIDS 90\u201390-90 goals in people who use heroin in Vietnam. Social determinants of health associated with ART and HIV viral suppression suggest that social support may be a key to facilitating both of these steps in the HIV care continuum.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-020-08538-3","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T19:04:49Z","timestamp":1585595089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["HIV care continuum characteristics among people with opioid use disorder and HIV in Vietnam: baseline results from the BRAVO study"],"prefix":"10.1186","volume":"20","author":[{"given":"Caroline","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Minh","family":"Giang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Bart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Kunkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Todd","family":"Korthuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"key":"8538_CR1","volume-title":"The twin epidemics of HIV and drug use: innovative strategies for healthy communities","author":"AMFAR","year":"2012","unstructured":"AMFAR. The twin epidemics of HIV and drug use: innovative strategies for healthy communitiesAMFAR Meeting Report; 2012."},{"key":"8538_CR2","unstructured":"Fiellin D, G.T.H.R. Combating the twin epidemics of hiv\/aids and drug addiction: opportunities for Progress and gaps in scale: CSIS Task Force; 2008."},{"key":"8538_CR3","unstructured":"DECISION OF THE PRIME MINISTER approving the National Strategy on HIV\/AIDS prevention and control in Viet Nam till 2010 with a vision to 2020, S.R.o. Vietnam, Editor. 2004."},{"key":"8538_CR4","unstructured":"HIV\/AIDS, T.J.U.N.P.o., 90\u201390-90 An ambitious treatment target to help end the AIDS epidemic. 2014."},{"issue":"5","key":"8538_CR5","doi-asserted-by":"publisher","first-page":"e0126659","DOI":"10.1371\/journal.pone.0126659","volume":"10","author":"VT Nguyen","year":"2015","unstructured":"Nguyen VT, et al. Expenditure analysis of HIV testing and counseling services using the Cascade framework in Vietnam. PLoS One. 2015;10(5):e0126659.","journal-title":"PLoS One"},{"key":"8538_CR6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/1472-6963-12-483","volume":"12","author":"M Fujita","year":"2012","unstructured":"Fujita M, et al. A new analytical framework of \u2018continuum of prevention and care' to maximize HIV case detection and retention in care in Vietnam. BMC Health Serv Res. 2012;12:483.","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"8538_CR7","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1258\/ijsa.2008.008389","volume":"20","author":"MR Jordan","year":"2009","unstructured":"Jordan MR, et al. Correlates of HIV-1 viral suppression in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam. Int J STD AIDS. 2009;20(6):418\u201322.","journal-title":"Int J STD AIDS"},{"key":"8538_CR8","volume-title":"USAID provides tools to ensure smooth antiretroviral therapy handover","author":"USAID","year":"2018","unstructured":"USAID. USAID provides tools to ensure smooth antiretroviral therapy handover; 2018."},{"key":"8538_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugpo.2015.12.005","volume":"28","author":"D Werb","year":"2016","unstructured":"Werb D, et al. The effectiveness of compulsory drug treatment: a systematic review. Int J Drug Policy. 2016;28:1\u20139.","journal-title":"Int J Drug Policy"},{"key":"8538_CR10","doi-asserted-by":"publisher","first-page":"732484","DOI":"10.1155\/2012\/732484","volume":"2012","author":"TT Nguyen","year":"2012","unstructured":"Nguyen TT, et al. Methadone maintenance therapy in Vietnam: an overview and scaling-up plan. Adv Prev Med. 2012;2012:732484.","journal-title":"Adv Prev Med"},{"key":"8538_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jsat.2016.07.003","volume":"69","author":"D Nguyen Bich","year":"2016","unstructured":"Nguyen Bich D, et al. HIV Patients' preference for integrated models of addiction and HIV treatment in Vietnam. J Subst Abus Treat. 2016;69:57\u201363.","journal-title":"J Subst Abus Treat"},{"key":"8538_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.addbeh.2018.05.031","volume":"85","author":"R Shrestha","year":"2018","unstructured":"Shrestha R, Copenhaver MM. Viral suppression among HIV-infected methadone-maintained patients: the role of ongoing injection drug use and adherence to antiretroviral therapy (ART). Addict Behav. 2018;85:88\u201393.","journal-title":"Addict Behav"},{"issue":"8","key":"8538_CR13","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/cid\/ciw416","volume":"63","author":"AJ Low","year":"2016","unstructured":"Low AJ, et al. Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and meta-analysis. Clin Infect Dis. 2016;63(8):1094\u2013104.","journal-title":"Clin Infect Dis"},{"key":"8538_CR14","unstructured":"Karki P, Shrestha R, Huedo-Medina TB, Copenhaver M. The impact of methadone maintenance treatment on HIV risk behaviors among high-risk injection drug users: a systematic review. Evid Based Med Public Health. 2016;2:e1229."},{"issue":"3","key":"8538_CR15","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s10461-017-1808-4","volume":"22","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, et al. The impact of substance use on adherence to antiretroviral therapy among HIV-infected women in the United States. AIDS Behav. 2018;22(3):896\u2013908.","journal-title":"AIDS Behav"},{"key":"8538_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12879-015-0913-0","volume":"15","author":"P Azar","year":"2015","unstructured":"Azar P, et al. Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis. BMC Infect Dis. 2015;15:193.","journal-title":"BMC Infect Dis"},{"key":"8538_CR17","doi-asserted-by":"publisher","unstructured":"Tanuma J, Matsumoto S, Haneuse S, Cuong DD, Vu TV, Thuy P, Dung NT, Dung N, Trung NV, Kinh NV, Oka S. Long-term viral suppression and immune recovery during first-line antiretroviral therapy: a study of an HIV-infected adult cohort in Hanoi, Vietnam. J Int AIDS Soc. 2017;20(4):e25030. https:\/\/doi.org\/10.1002\/jia2.25030.","DOI":"10.1002\/jia2.25030"},{"issue":"2","key":"8538_CR18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S2055-6640(20)30466-0","volume":"2","author":"S Rangarajan","year":"2016","unstructured":"Rangarajan S, et al. Factors associated with HIV viral load suppression on antiretroviral therapy in Vietnam. J Virus Erad. 2016;2(2):94\u2013101.","journal-title":"J Virus Erad"},{"key":"8538_CR19","unstructured":"Abott RealTime HIV 1 Viral Load Assay. [cited 2019 July 16]; Available from: https:\/\/www.molecular.abbott\/us\/en\/products\/infectious-disease\/realtime-hiv-1-viral-load."},{"issue":"11","key":"8538_CR20","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1111\/add.13505","volume":"111","author":"KA Bradley","year":"2016","unstructured":"Bradley KA, et al. Predictive validity of clinical AUDIT-C alcohol screening scores and changes in scores for three objective alcohol-related outcomes in a veterans affairs population. Addiction. 2016;111(11):1975\u201384.","journal-title":"Addiction"},{"issue":"8","key":"8538_CR21","first-page":"1842","volume":"22","author":"KA Bradley","year":"1998","unstructured":"Bradley KA, et al. The AUDIT alcohol consumption questions: reliability, validity, and responsiveness to change in older male primary care patients. Alcohol Clin Exp Res. 1998;22(8):1842\u20139.","journal-title":"Alcohol Clin Exp Res"},{"issue":"16","key":"8538_CR22","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","volume":"158","author":"K Bush","year":"1998","unstructured":"Bush K, et al. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory care quality improvement project (ACQUIP). Alcohol use disorders identification test. Arch Intern Med. 1998;158(16):1789\u201395.","journal-title":"Arch Intern Med"},{"issue":"7","key":"8538_CR23","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/j.1530-0277.2007.00403.x","volume":"31","author":"KA Bradley","year":"2007","unstructured":"Bradley KA, et al. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007;31(7):1208\u201317.","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"8538_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13722-018-0114-4","volume":"13","author":"PT Korthuis","year":"2018","unstructured":"Korthuis PT, Edelman EJ. Substance use and the HIV care continuum: important advances. Addict Sci Clin Pract. 2018;13(1):13.","journal-title":"Addict Sci Clin Pract"},{"key":"8538_CR25","doi-asserted-by":"crossref","unstructured":"Lovibond SH, L.P., Manual for the depression anxiety stress scales. Vol. 2. 1995, Sydney: Psychology Foundation of Australia.","DOI":"10.1037\/t01004-000"},{"key":"8538_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-244X-13-24","volume":"13","author":"TD Tran","year":"2013","unstructured":"Tran TD, Tran T, Fisher J. Validation of the depression anxiety stress scales (DASS) 21 as a screening instrument for depression and anxiety in a rural community-based cohort of northern Vietnamese women. BMC Psychiatry. 2013;13:24.","journal-title":"BMC Psychiatry"},{"issue":"12","key":"8538_CR27","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"8538_CR28","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1600693","volume":"375","author":"MS Cohen","year":"2016","unstructured":"Cohen MS, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830\u20139.","journal-title":"N Engl J Med"},{"key":"8538_CR29","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1186\/s12879-015-1309-x","volume":"15","author":"Y Liu","year":"2015","unstructured":"Liu Y, et al. Predictors of antiretroviral therapy initiation: a cross-sectional study among Chinese HIV-infected men who have sex with men. BMC Infect Dis. 2015;15:570.","journal-title":"BMC Infect Dis"},{"issue":"Suppl 4","key":"8538_CR30","doi-asserted-by":"publisher","first-page":"e25114","DOI":"10.1002\/jia2.25114","volume":"21","author":"TK Phillips","year":"2018","unstructured":"Phillips TK, et al. Linkage to care, mobility and retention of HIV-positive postpartum women in antiretroviral therapy services in South Africa. J Int AIDS Soc. 2018;21(Suppl 4):e25114.","journal-title":"J Int AIDS Soc"},{"issue":"8","key":"8538_CR31","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1080\/09540120802657555","volume":"21","author":"SA Springer","year":"2009","unstructured":"Springer SA, Chen S, Altice F. Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy. AIDS Care. 2009;21(8):976\u201383.","journal-title":"AIDS Care"},{"issue":"3","key":"8538_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s11904-014-0220-1","volume":"11","author":"OA Uthman","year":"2014","unstructured":"Uthman OA, et al. Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV\/AIDS Rep. 2014;11(3):291\u2013307.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"8","key":"8538_CR33","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1007\/s10461-017-1829-z","volume":"21","author":"J Velloza","year":"2017","unstructured":"Velloza J, et al. Depression and ART initiation among HIV Serodiscordant couples in Kenya and Uganda. AIDS Behav. 2017;21(8):2509\u201318.","journal-title":"AIDS Behav"},{"issue":"2","key":"8538_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/QAD.0000000000001323","volume":"31","author":"CR Sudfeld","year":"2017","unstructured":"Sudfeld CR, et al. Depression at antiretroviral therapy initiation and clinical outcomes among a cohort of Tanzanian women living with HIV. AIDS. 2017;31(2):263\u201371.","journal-title":"AIDS"},{"issue":"6","key":"8538_CR35","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1007\/s10461-016-1442-6","volume":"21","author":"R Cholera","year":"2017","unstructured":"Cholera R, et al. Depression and engagement in care among newly diagnosed HIV-infected adults in Johannesburg, South Africa. AIDS Behav. 2017;21(6):1632\u201340.","journal-title":"AIDS Behav"},{"issue":"2","key":"8538_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1089\/apc.2016.0214","volume":"31","author":"J Tao","year":"2017","unstructured":"Tao J, et al. Impact of depression and anxiety on initiation of antiretroviral therapy among men who have sex with men with newly diagnosed HIV infections in China. AIDS Patient Care STDs. 2017;31(2):96\u2013104.","journal-title":"AIDS Patient Care STDs"},{"issue":"6","key":"8538_CR37","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s10461-013-0674-y","volume":"18","author":"TM Goodness","year":"2014","unstructured":"Goodness TM, et al. Depressive symptoms and antiretroviral therapy (ART) initiation among HIV-infected Russian drinkers. AIDS Behav. 2014;18(6):1085\u201393.","journal-title":"AIDS Behav"},{"key":"8538_CR38","doi-asserted-by":"publisher","unstructured":"Parruti G, Manzoli L, Toro PM, et al. Long-term adherence to first-line highly active antiretroviral therapy in a hospital-based cohort: predictors and impact on virologic response and relapse. AIDS Patient Care STDS. 2006;20(1):48\u201356. https:\/\/doi.org\/10.1089\/apc.2006.20.48.","DOI":"10.1089\/apc.2006.20.48"},{"issue":"1","key":"8538_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1089\/apc.2006.20.48","volume":"20","author":"G Parruti","year":"2006","unstructured":"Parruti G, et al. Long-term adherence to first-line highly active antiretroviral therapy in a hospital-based cohort: predictors and impact on virologic response and relapse. AIDS Patient Care STDs. 2006;20(1):48\u201356.","journal-title":"AIDS Patient Care STDs"},{"issue":"8","key":"8538_CR40","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s10461-016-1297-x","volume":"20","author":"A Ustinov","year":"2016","unstructured":"Ustinov A, et al. Psychiatric distress, drug use, and HIV viral load suppression in Russia. AIDS Behav. 2016;20(8):1603\u20138.","journal-title":"AIDS Behav"},{"key":"8538_CR41","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.drugalcdep.2014.09.780","volume":"147","author":"MB Feldman","year":"2015","unstructured":"Feldman MB, et al. Crystal methamphetamine use and HIV medical outcomes among HIV-infected men who have sex with men accessing support services in New York. Drug Alcohol Depend. 2015;147:266\u201371.","journal-title":"Drug Alcohol Depend"},{"key":"8538_CR42","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.drugalcdep.2019.05.007","volume":"202","author":"D Goodman-Meza","year":"2019","unstructured":"Goodman-Meza D, et al. Methamphetamine use drives decreases in viral suppression for people living with HIV released from a large municipal jail: results of the LINK LA clinical trial. Drug Alcohol Depend. 2019;202:178\u201384.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"8538_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/apc.2017.0306","volume":"32","author":"JE Hood","year":"2018","unstructured":"Hood JE, et al. The changing burden of HIV attributable to methamphetamine among men who have sex with men in King County, Washington. AIDS Patient Care STDs. 2018;32(6):223\u201333.","journal-title":"AIDS Patient Care STDs"},{"issue":"7","key":"8538_CR44","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.addbeh.2011.02.001","volume":"36","author":"N Fairbairn","year":"2011","unstructured":"Fairbairn N, et al. Crystal methamphetamine injection predicts slower HIV RNA suppression among injection drug users. Addict Behav. 2011;36(7):762\u20133.","journal-title":"Addict Behav"},{"issue":"5","key":"8538_CR45","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/09540121.2018.1431385","volume":"30","author":"W Aibibula","year":"2018","unstructured":"Aibibula W, et al. Association between depressive symptoms, CD4 count and HIV viral suppression among HIV-HCV co-infected people. AIDS Care. 2018;30(5):643\u20139.","journal-title":"AIDS Care"},{"issue":"11","key":"8538_CR46","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1080\/09540121.2016.1189496","volume":"28","author":"AD Castel","year":"2016","unstructured":"Castel AD, et al. Disparities in achieving and sustaining viral suppression among a large cohort of HIV-infected persons in care \u2013 Washington, DC. AIDS Care. 2016;28(11):1355\u201364.","journal-title":"AIDS Care"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-08538-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-020-08538-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-08538-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T23:12:14Z","timestamp":1617059534000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-020-08538-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["8538"],"URL":"https:\/\/doi.org\/10.1186\/s12889-020-08538-3","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,30]]},"assertion":[{"value":"26 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This project was approved by the OHSU Institutional Review Board and the Vietnam Ministry of Health Research Ethics Committee. Participants provided written consent to participate, which was securely filed. Consents were periodically audited by the study quality assurance monitor for appropriate completion.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No authors have financial conflicts of interest. Dr. Korthuis serves at principal investigator for NIH-funded studies that accept donated study medicine from Indivior (buprenorphine) and Alkermes (extended-release naltrexone).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"421"}}